• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种鞘氨醇激酶 2 形式敲除使小鼠心肌对缺血/再灌注损伤敏感,并降低对缺血预处理的反应性。

A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning.

机构信息

Liver Study Unit, Veterans Affairs Medical Center, San Francisco, CA 94121, USA.

出版信息

Oxid Med Cell Longev. 2011;2011:961059. doi: 10.1155/2011/961059. Epub 2011 Apr 18.

DOI:10.1155/2011/961059
PMID:21904650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3166792/
Abstract

Sphingosine kinase (SphK) exhibits two isoforms, SphK1 and SphK2. Both forms catalyze the synthesis of sphingosine 1-phosphate (S1P), a sphingolipid involved in ischemic preconditioning (IPC). Since the ratio of SphK1:SphK2 changes dramatically with aging, it is important to assess the role of SphK2 in IR injury and IPC. Langendorff mouse hearts were subjected to IR (30 min equilibration, 50 min global ischemia, and 40 min reperfusion). IPC consisted of 2 min of ischemia and 2 min of reperfusion for two cycles. At baseline, there were no differences in left ventricular developed pressure (LVDP), ± dP/dtmax, and heart rate between SphK2 null (KO) and wild-type (WT) hearts. In KO hearts, SphK2 activity was undetectable, and SphK1 activity was unchanged compared to WT. Total SphK activity was reduced by 53%. SphK2 KO hearts subjected to IR exhibited significantly more cardiac damage (37 ± 1% infarct size) compared with WT (28 ± 1% infarct size); postischemic recovery of LVDP was lower in KO hearts. IPC exerted cardioprotection in WT hearts. The protective effect of IPC against IR was diminished in KO hearts which had much higher infarction sizes (35 ± 2%) compared to the IPC/IR group in control hearts (12 ± 1%). Western analysis revealed that KO hearts had substantial levels of phosphorylated p38 which could predispose the heart to IR injury. Thus, deletion of the SphK2 gene sensitizes the myocardium to IR injury and diminishes the protective effect of IPC.

摘要

鞘氨醇激酶(SphK)有两种同工酶形式,SphK1 和 SphK2。这两种形式都能催化合成鞘氨醇 1-磷酸(S1P),S1P 是一种参与缺血预处理(IPC)的鞘脂。由于 SphK1:SphK2 的比例随着年龄的增长而剧烈变化,因此评估 SphK2 在 IR 损伤和 IPC 中的作用非常重要。Langendorff 小鼠心脏进行 IR(30 分钟平衡,50 分钟整体缺血和 40 分钟再灌注)。IPC 由 2 分钟缺血和 2 分钟再灌注两个周期组成。在基线时,SphK2 缺失(KO)和野生型(WT)心脏之间的左心室发展压(LVDP)、±dp/dtmax 和心率没有差异。在 KO 心脏中,SphK2 活性无法检测到,与 WT 相比 SphK1 活性不变。总 SphK 活性降低了 53%。与 WT 心脏(28 ± 1%梗死面积)相比,IR 后 SphK2 KO 心脏表现出明显更多的心脏损伤(37 ± 1%梗死面积);KO 心脏的 LVDP 再灌注后恢复较低。IPC 在 WT 心脏中发挥心脏保护作用。在 KO 心脏中,IPC 对 IR 的保护作用减弱,KO 心脏的梗死面积(35 ± 2%)明显高于对照心脏的 IPC/IR 组(12 ± 1%)。Western 分析显示,KO 心脏有大量磷酸化的 p38,这可能使心脏易受 IR 损伤。因此,SphK2 基因缺失使心肌对 IR 损伤敏感,并降低了 IPC 的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/15841982958a/OXIMED2011-961059.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/ad5872fa382b/OXIMED2011-961059.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/f01ecf1e9702/OXIMED2011-961059.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/71b169df880b/OXIMED2011-961059.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/86564efef2f2/OXIMED2011-961059.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/213cfc55a82c/OXIMED2011-961059.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/15841982958a/OXIMED2011-961059.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/ad5872fa382b/OXIMED2011-961059.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/f01ecf1e9702/OXIMED2011-961059.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/71b169df880b/OXIMED2011-961059.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/86564efef2f2/OXIMED2011-961059.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/213cfc55a82c/OXIMED2011-961059.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f60/3166792/15841982958a/OXIMED2011-961059.006.jpg

相似文献

1
A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning.一种鞘氨醇激酶 2 形式敲除使小鼠心肌对缺血/再灌注损伤敏感,并降低对缺血预处理的反应性。
Oxid Med Cell Longev. 2011;2011:961059. doi: 10.1155/2011/961059. Epub 2011 Apr 18.
2
A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.鞘氨醇激酶1突变使心肌对缺血/再灌注损伤敏感。
Cardiovasc Res. 2007 Oct 1;76(1):41-50. doi: 10.1016/j.cardiores.2007.05.029. Epub 2007 Jun 8.
3
Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation.缺血后适应通过激活鞘氨醇激酶同工型-1保护离体小鼠心脏免受缺血/再灌注损伤。
Cardiovasc Res. 2008 Jul 1;79(1):134-40. doi: 10.1093/cvr/cvn065. Epub 2008 Mar 11.
4
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.1-磷酸鞘氨醇是一种由缺血预处理和后处理释放的重要内源性心脏保护剂。
Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1429-35. doi: 10.1152/ajpheart.00358.2009. Epub 2009 Jul 31.
5
Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.巨噬细胞移动抑制因子在缺血预处理介导的心脏保护中发挥重要作用。
Clin Sci (Lond). 2019 Mar 5;133(5):665-680. doi: 10.1042/CS20181013. Print 2019 Mar 15.
6
Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.缺血预处理和β-肾上腺素能预处理对心肌细胞凋亡的抑制作用依赖于p38丝裂原活化蛋白激酶。
Cardiovasc Drugs Ther. 2006 Feb;20(1):13-25. doi: 10.1007/s10557-006-6257-7.
7
Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism.低剂量的N,N-二甲基鞘氨醇具有心脏保护作用,并通过一种蛋白激酶Cε依赖性机制激活胞质鞘氨醇激酶。
Cardiovasc Res. 2006 Sep 1;71(4):725-34. doi: 10.1016/j.cardiores.2006.06.010. Epub 2006 Jun 12.
8
FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.FTY720通过一种独立于鞘氨醇激酶2且不同于S1P或缺血后处理的机制使离体灌注心脏产生后处理效应。
Med Sci Monit Basic Res. 2013 Apr 9;19:126-32. doi: 10.12659/MSMBR.883877.
9
STAT subtype specificity and ischemic preconditioning in mice: is STAT-3 enough?STAT 亚型特异性与小鼠的缺血预处理:STAT-3 足够吗?
Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H522-6. doi: 10.1152/ajpheart.00231.2010. Epub 2010 Dec 3.
10
Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms.胰岛素通过 Akt 依赖性机制抑制缺血预处理介导的心脏保护作用。
J Mol Cell Cardiol. 2013 Nov;64:20-9. doi: 10.1016/j.yjmcc.2013.08.005. Epub 2013 Aug 30.

引用本文的文献

1
ATF3 regulates SPHK1 in cardiomyocyte injury via endoplasmic reticulum stress.ATF3 通过内质网应激调节心肌细胞损伤中的 SPHK1。
Immun Inflamm Dis. 2023 Sep;11(9):e998. doi: 10.1002/iid3.998.
2
Differential Expression of Sphingolipid Metabolizing Enzymes in Spontaneously Hypertensive Rats: A Possible Substrate for Susceptibility to Brain and Kidney Damage.鞘脂代谢酶在自发性高血压大鼠中的差异表达:脑和肾损伤易感性的可能底物。
Int J Mol Sci. 2021 Apr 6;22(7):3796. doi: 10.3390/ijms22073796.
3
Sphingolipids in the Heart: From Cradle to Grave.

本文引用的文献

1
Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration.线粒体中的鞘氨醇激酶 2 产生的鞘氨醇-1-磷酸与抑素 2 相互作用,调节复合物 IV 的组装和呼吸。
FASEB J. 2011 Feb;25(2):600-12. doi: 10.1096/fj.10-167502. Epub 2010 Oct 19.
2
Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning.鞘氨醇可保护衰老心脏免于缺血/再灌注损伤:优于鞘氨醇 1-磷酸和缺血预处理及后处理。
Oxid Med Cell Longev. 2009 Jul-Aug;2(3):146-51. doi: 10.4161/oxim.2.3.8622.
3
心脏中的神经鞘脂:从摇篮到坟墓。
Front Endocrinol (Lausanne). 2020 Sep 15;11:652. doi: 10.3389/fendo.2020.00652. eCollection 2020.
4
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System.鞘氨醇激酶与1-磷酸鞘氨醇受体:在心血管系统中的信号传导与作用
Front Pharmacol. 2017 Aug 23;8:556. doi: 10.3389/fphar.2017.00556. eCollection 2017.
5
Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with Bcl-2 via its putative BH3 domain.鞘氨醇激酶2通过其假定的BH3结构域与Bcl-2相互作用来激活自噬并保护神经元免受缺血性损伤。
Cell Death Dis. 2017 Jul 6;8(7):e2912. doi: 10.1038/cddis.2017.289.
6
Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?鞘氨醇-1-磷酸受体:它们在心脏纤维化中具有治疗潜力吗?
Front Pharmacol. 2017 Jun 2;8:296. doi: 10.3389/fphar.2017.00296. eCollection 2017.
7
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.哺乳动物鞘氨醇激酶(SphK)同工酶及异构体表达:鞘氨醇激酶作为肿瘤靶点面临的挑战
Oncotarget. 2017 May 30;8(22):36898-36929. doi: 10.18632/oncotarget.16370.
8
Implication of sphingosin-1-phosphate in cardiovascular regulation.鞘氨醇-1-磷酸在心血管调节中的意义。
Front Biosci (Landmark Ed). 2016 Jun 1;21(7):1296-313. doi: 10.2741/4458.
9
Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.鞘氨醇激酶1选择性抑制剂PF-543对肺动脉高压缺氧模型中动脉和心脏重塑的影响。
Cell Signal. 2016 Aug;28(8):946-55. doi: 10.1016/j.cellsig.2016.03.014. Epub 2016 Apr 6.
10
Preconditioning stimuli induce autophagy via sphingosine kinase 2 in mouse cortical neurons.预处理刺激通过鞘氨醇激酶 2 在小鼠皮质神经元中诱导自噬。
J Biol Chem. 2014 Jul 25;289(30):20845-57. doi: 10.1074/jbc.M114.578120.
Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning.
缝隙连接蛋白-I/P2X7 嘌呤能受体通道介导缺血预处理和后处理诱导的心脏保护剂释放。
J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):190-5. doi: 10.1177/1074248409360356. Epub 2010 Mar 3.
4
Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implications.鞘氨醇-1-磷酸受体:聚焦配体诱导的细胞内运输及其功能意义。
Mol Cells. 2010 Feb 28;29(2):99-104. doi: 10.1007/s10059-010-0041-z. Epub 2010 Jan 29.
5
A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.化学遗传学方法揭示,二磷酸化激活的 p38alpha MAPK 加重心肌梗死,而 SB203580 的直接结合可预防这种作用。
J Biol Chem. 2010 Jan 29;285(5):2968-75. doi: 10.1074/jbc.M109.079228. Epub 2009 Dec 7.
6
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.1-磷酸鞘氨醇是一种由缺血预处理和后处理释放的重要内源性心脏保护剂。
Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1429-35. doi: 10.1152/ajpheart.00358.2009. Epub 2009 Jul 31.
7
Lipid signalling in cardiovascular pathophysiology.心血管病理生理学中的脂质信号传导
Cardiovasc Res. 2009 May 1;82(2):171-4. doi: 10.1093/cvr/cvp096. Epub 2009 Mar 18.
8
Loss of cardioprotection with ageing.随着年龄增长心脏保护作用丧失。
Cardiovasc Res. 2009 Jul 15;83(2):247-61. doi: 10.1093/cvr/cvp033. Epub 2009 Jan 28.
9
Targeting sphingosine-1-phosphate signalling for cardioprotection.靶向鞘氨醇-1-磷酸信号通路以实现心脏保护
Curr Opin Pharmacol. 2009 Apr;9(2):194-201. doi: 10.1016/j.coph.2008.11.002. Epub 2008 Dec 11.
10
Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.鞘氨醇激酶在肾脏缺血再灌注损伤中的不同作用
Kidney Int. 2009 Jan;75(2):167-75. doi: 10.1038/ki.2008.400. Epub 2008 Oct 29.